Aimei Health Technology Co., Ltd. is a prominent player in the healthcare industry, recognized for its commitment to enhancing patient care through advanced medical technology and innovative health solutions. The company specializes in the design and manufacture of cutting-edge medical devices and comprehensive health management systems aimed at improving patient outcomes and streamlining healthcare delivery. With a robust focus on research and development, alongside strategic partnerships, Aimei is strategically positioned for sustainable growth in the rapidly changing global healthcare environment, making it an attractive investment opportunity for institutional investors.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -1.08% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-1.32 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -43.40% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $1.44M |
| % Insiders | 0.00% |
| % Institutions | 0.07% |
Volatility is currently contracting
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AFJKU and any ticker you trade — then tracks every position and per-strategy win rate.